Walgreen Boots Alliance

WBA-Q

Get Alerts52 watching

NASDAQ:WBA

42.96
1.13 (2.69%)
Walgreens Boots Alliance, Inc. is an American holding company headquartered in Deerfield, Illinois that owns Walgreens, Boots, and a number of pharmaceutical manufacturing, wholesale and distribution companies.
More at Wikipedia
WBA Fundamental Data  by TradingView
WBA Chart  by TradingView
Technical Analysis for WBA  by TradingView

Analysis and Opinions about WBA-Q

Signal
Opinion
Expert
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
June 14, 2019

$79.57 is his model price, 50% higher than the current price. Dirt cheap now. He has recommended this in the past. The Amazon fear is overdone. Be patient with this value name.

Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
June 14, 2019

$79.57 is his model price, 50% higher than the current price. Dirt cheap now. He has recommended this in the past. The Amazon fear is overdone. Be patient with this value name.

specialty stores
0 Comments
Brian Acker, CA

☆ Unlock Ratings

Price
$52.570
Owned
Yes
N/A
N/A
Walgreen Boots Alliance (WBA-Q)
May 30, 2019
He was not happy with their last earnings report. There was a weakening on margins on their generic drug business and they are being affected with BREXIT because of their affiliation with Boots. He owns CVS-N who have a more vibrant long term plan. WBA-Q does not have a catalyst.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
May 30, 2019
He was not happy with their last earnings report. There was a weakening on margins on their generic drug business and they are being affected with BREXIT because of their affiliation with Boots. He owns CVS-N who have a more vibrant long term plan. WBA-Q does not have a catalyst.
specialty stores
0 Comments
Gordon Reid

☆ Unlock Ratings

Price
$50.550
Owned
No
HOLD
HOLD
Walgreen Boots Alliance (WBA-Q)
May 29, 2019
He sill owns WBA-Q. Both have been under tremendous pressure. He feels the entry of Amazon in to mail order prescriptions has hurt along with a move towards generic pricing on drugs. He feels it is way over done. These companies are foundations within the US. At some point they will bottom out, but he is not ready to add to his holdings at this point.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
May 29, 2019
He sill owns WBA-Q. Both have been under tremendous pressure. He feels the entry of Amazon in to mail order prescriptions has hurt along with a move towards generic pricing on drugs. He feels it is way over done. These companies are foundations within the US. At some point they will bottom out, but he is not ready to add to his holdings at this point.
specialty stores
0 Comments
Don Lato

☆ Unlock Ratings

Price
$51.130
Owned
Unknown
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
May 23, 2019
It is global. It will have headline noise because of the election. It could bounce back but is under pressure from dispensing fees. There are other ways to get dividend growth. 75% of their business is retail.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
May 23, 2019
It is global. It will have headline noise because of the election. It could bounce back but is under pressure from dispensing fees. There are other ways to get dividend growth. 75% of their business is retail.
specialty stores
0 Comments
Robert Lauzon

☆ Unlock Ratings

Price
$51.610
Owned
Unknown
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
vs. Walgreen Still cheap. $82.60 is his target price. Some stocks you go to war with when the market or sector is negative, when investors beat up a stock. You can be contrarian and do very well with this.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
vs. Walgreen Still cheap. $82.60 is his target price. Some stocks you go to war with when the market or sector is negative, when investors beat up a stock. You can be contrarian and do very well with this.
specialty stores
0 Comments
Brian Acker, CA

☆ Unlock Ratings

Price
$54.100
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
(A Top Pick Apr 25/18, Down 16%) He sold upon news that its generic drug margins were deteriorating. You must look at your stocks with fresh eyes when news arises. Have an unemotional sell discipline.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
(A Top Pick Apr 25/18, Down 16%) He sold upon news that its generic drug margins were deteriorating. You must look at your stocks with fresh eyes when news arises. Have an unemotional sell discipline.
specialty stores
0 Comments
Gordon Reid

☆ Unlock Ratings

Price
$54.100
Owned
No
PARTIAL BUY
PARTIAL BUY
Walgreen Boots Alliance (WBA-Q)
April 11, 2019
The PE is lower than historically. He historically owned CVS-N. The problem with WBA-N is the political noise around drug pricing and these companies are just middlemen. He sold CVS-N a while ago. There is a lot of risk in the names for the next 5 years. Buy a half position in the name and buy the rest on later on weakness.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
April 11, 2019
The PE is lower than historically. He historically owned CVS-N. The problem with WBA-N is the political noise around drug pricing and these companies are just middlemen. He sold CVS-N a while ago. There is a lot of risk in the names for the next 5 years. Buy a half position in the name and buy the rest on later on weakness.
specialty stores
0 Comments
Bryden Teich

☆ Unlock Ratings

Price
$54.713
Owned
No
TOP PICK
TOP PICK
Walgreen Boots Alliance (WBA-Q)
March 13, 2019
It's suffered the double-whammy of eliminating drug pricing talk by politicians in the U.S. and fears of Amazon getting into the pharma space. WBA has increased its dividend 43 years in a row and expect one in June. Trades at lower than 10x earnings. He thinks pricing fears are overblown. Targets this in the mid-$70s within 12 months. (Analysts’ price target is $74.35)
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
March 13, 2019
It's suffered the double-whammy of eliminating drug pricing talk by politicians in the U.S. and fears of Amazon getting into the pharma space. WBA has increased its dividend 43 years in a row and expect one in June. Trades at lower than 10x earnings. He thinks pricing fears are overblown. Targets this in the mid-$70s within 12 months. (Analysts’ price target is $74.35)
specialty stores
0 Comments
Don Lato

☆ Unlock Ratings

Price
$61.900
Owned
Yes
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
March 11, 2019
He decided to get out of CVS-T because they were on the defensive too much. In the US a lot of funding for drugs comes from the government. They are always looking for ways to bring down healthcare costs in the US. CVS-T keep making acquisitions to make the company make sense. He would probably prefer WBA-Q.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
March 11, 2019
He decided to get out of CVS-T because they were on the defensive too much. In the US a lot of funding for drugs comes from the government. They are always looking for ways to bring down healthcare costs in the US. CVS-T keep making acquisitions to make the company make sense. He would probably prefer WBA-Q.
specialty stores
0 Comments
Teal Linde

☆ Unlock Ratings

Price
$60.680
Owned
Unknown
DON'T BUY
DON'T BUY
Walgreen Boots Alliance (WBA-Q)
March 11, 2019
It looks shaky now. Hopefeully it stays in the $60-80 range. If it breaks below $60, you're in trouble. Have a short leash on this.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
March 11, 2019
It looks shaky now. Hopefeully it stays in the $60-80 range. If it breaks below $60, you're in trouble. Have a short leash on this.
specialty stores
0 Comments
Elliott Fishman

☆ Unlock Ratings

Price
$60.680
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
Walgreen Boots Alliance (WBA-Q)
December 21, 2018
(A Top Pick Nov 30/17, Down 3%) Holding its own given the recent drop in markets in general. Just in the last week it has weaken based on a weak report from GoldmanSachs. They have recently guided earnings in line with market expectations. The European market slowdown is creating headwinds. It trades at less than 10 times earnings and over 2% yield with rising dividends expected next year.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
December 21, 2018
(A Top Pick Nov 30/17, Down 3%) Holding its own given the recent drop in markets in general. Just in the last week it has weaken based on a weak report from GoldmanSachs. They have recently guided earnings in line with market expectations. The European market slowdown is creating headwinds. It trades at less than 10 times earnings and over 2% yield with rising dividends expected next year.
specialty stores
0 Comments
Don Lato

☆ Unlock Ratings

Price
$67.260
Owned
Unknown
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
December 19, 2018
They have 13,000 stores in the US and just bought many more stores recently. They struggled to bring those into the structure, but feels they are going to do well. Trading at 12.5 times earnings (about 30% discount to normal). It is a Dow component. He thinks there are good things to come.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
December 19, 2018
They have 13,000 stores in the US and just bought many more stores recently. They struggled to bring those into the structure, but feels they are going to do well. Trading at 12.5 times earnings (about 30% discount to normal). It is a Dow component. He thinks there are good things to come.
specialty stores
0 Comments
Gordon Reid

☆ Unlock Ratings

Price
$73.290
Owned
Yes
WAIT
WAIT
Walgreen Boots Alliance (WBA-Q)
December 3, 2018
Maybe the CVS acqusition of Aetna is synergistic by putting Aetna facilities besides CVS locations, but will this drive volume within the pharamcy? He's not sure. Trades at 10x earnings. With this purchase, their debt is higher. Wait a couple of quarters to see if the acqusition pans out.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
December 3, 2018
Maybe the CVS acqusition of Aetna is synergistic by putting Aetna facilities besides CVS locations, but will this drive volume within the pharamcy? He's not sure. Trades at 10x earnings. With this purchase, their debt is higher. Wait a couple of quarters to see if the acqusition pans out.
specialty stores
0 Comments
Paul MacDonald

☆ Unlock Ratings

Price
$85.690
Owned
Unknown
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
November 26, 2018
He likes this company. It has been trading quite well. It looks undervalued and a nice little dividend which is sustainable. A good opportunity here.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
November 26, 2018
He likes this company. It has been trading quite well. It looks undervalued and a nice little dividend which is sustainable. A good opportunity here.
specialty stores
0 Comments
Matt Kacur

☆ Unlock Ratings

Price
$81.700
Owned
No
TOP PICK
TOP PICK
Walgreen Boots Alliance (WBA-Q)
November 2, 2018
This sector was hit when Amazon was thought to be invading the space. His model has just given a positive buy signal. His model price is $100. Yield 2.2%. (Analysts’ price target is $76.14)
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
November 2, 2018
This sector was hit when Amazon was thought to be invading the space. His model has just given a positive buy signal. His model price is $100. Yield 2.2%. (Analysts’ price target is $76.14)
specialty stores
0 Comments
Brian Acker, CA

☆ Unlock Ratings

Price
$79.300
Owned
Yes
Showing 16 to 30 of 211 entries
Previous
Next Page
© Stockchase Inc.